ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 005

Magnetic Resonance Enterography Detected Sacroiliitis in Pediatric Crohn’s Disease: A Retrospective Cohort Study

Aaisham Ali1, Vishal Kalia2, Ian Ross2, Luke Daichendt3, Julia Sawicka4, Michael R Miller5, Sarah Wells6, Eileen Crowley6 and Roberta A Berard7, 1Schulich School of Medicine & Dentistry, Pediatrics, London Health Sciences Centre, London, ON, Canada, 2Department of Medical Imaging, Western University, 3Schulich School of Medicine & Dentistry, Western University, 4Western University, 5Department of Pediatrics, Children's Hospital, London Health Sciences Centre, 6London Children's Hospital, ON, Canada, 7London Health Sciences Centre, London, ON, Canada

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Musculoskeletal (MSK) manifestations are amongst the most common extraintestinal manifestations (EIMs) in pediatric Crohn’s disease (CD). MSK EIMs contribute to reduced quality of life and morbidity and are associated with increased severity of bowel disease activity in pediatric IBD (Derfalvi B et al., 2022). Despite this, there is a relative paucity of literature describing MSK EIMs, and specifically, asymptomatic sacroiliitis (SI) is even less commonly described. One prior pediatric study identified asymptomatic SI in 15% of patients (5/34) (Giani T et al., 2020). We aimed to determine the prevalence of asymptomatic SI detected on magnetic resonance enterography (MRE) and explore its association with clinical, laboratory, and disease characteristics over time.

Methods: In this single-center, retrospective cohort study, pediatric patients diagnosed with CD (< 1 year) who underwent MRE at a children’s hospital over four years (2019-2023) were included. Patients with inadequate sacroiliac joint imaging or known spondyloarthritis were excluded. MRE sacroiliac joint images including coronal T1, axial T2, and coronal T2W sequences with fat suppression were evaluated by a fellowship-trained adult MSK radiologist, with a secondary read by a fellowship-trained pediatric MSK radiologist to establish inter-rater reliability. Patient follow-up data were collected over a 2-year time frame. Descriptive statistics were used to describe baseline characteristics and group comparisons. Trends over time for continuous and dichotomous outcomes were examined using linear and generalized logistic regression mixed models, respectively.

Results: Among 133 patients with CD (mean age 13.3 ± 3.0 years; 41% female), 9% (12/133) demonstrated SI on MRE: 5 acute, 4 chronic, and 3 acute-on-chronic [Table 1]. Inter-rater reliability demonstrated substantial agreement (Cohen’s kappa 0.78). Except for painful joints (p=0.016), baseline clinical and laboratory parameters, including CRP, ESR and wPCDAI, did not differ significantly between groups. Over two years, patients with SI demonstrated fewer hospital admissions (p=0.044), greater decreases in ESR (p=0.032), and greater decreases in WBC counts (p=0.042). Notably, only one third (4/12) of patients with SI on MRE had a rheumatology assessment during follow-up.

Conclusion: Asymptomatic SI was detected in nearly one in ten pediatric CD patients through routine MRE, highlighting a potential role for enterography as an opportunistic screening tool for axial disease. These findings underscore the need for systematic rheumatology assessment of these patients and prospective studies to clarify the clinical significance of subclinical SI in pediatric IBD.

Table 1: Clinical characteristics of pediatric Crohn’s disease patients with magnetic resonance enterography imaging.Supporting image 1a. Acute sacroiliitis defined by presence of bone marrow edema, osteitis, joint space inflammation, enthesitis, capsulitis, or joint effusion. b. Chronic sacroiliitis defined by presence of periarticular sclerosis, fat metaplasia, backfill, erosions, or ankylosis. c. Acute on chronic sacroiliitis defined by presence of mixed features of acute and chronic sacroilittis.
WPCDAI: weighted pediatric Crohn’s disease activity index. SES-CD: simple endoscopic score for Crohn’s disease. MSK: musculoskeletal. CRP: c-reactive protein. ESR: erythrocyte sedimentation rate.


Disclosures: A. Ali: None; V. Kalia: None; I. Ross: None; L. Daichendt: None; J. Sawicka: None; M. Miller: None; S. Wells: None; E. Crowley: Abbvie, 5, Alimentiv Inc., 2, Pfizer, 5, Sanofi, 2; R. Berard: AbbVie/Abbott, 1, Celltrion, 12, advisory board.

To cite this abstract in AMA style:

Ali A, Kalia V, Ross I, Daichendt L, Sawicka J, Miller M, Wells S, Crowley E, Berard R. Magnetic Resonance Enterography Detected Sacroiliitis in Pediatric Crohn’s Disease: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/magnetic-resonance-enterography-detected-sacroiliitis-in-pediatric-crohns-disease-a-retrospective-cohort-study/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/magnetic-resonance-enterography-detected-sacroiliitis-in-pediatric-crohns-disease-a-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology